3-10049351-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001018115.3(FANCD2):​c.1414-23T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.299 in 1,117,110 control chromosomes in the GnomAD database, including 48,671 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 13140 hom., cov: 30)
Exomes 𝑓: 0.28 ( 35531 hom. )

Consequence

FANCD2
NM_001018115.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.483

Publications

9 publications found
Variant links:
Genes affected
FANCD2 (HGNC:3585): (FA complementation group D2) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group D2. This protein is monoubiquinated in response to DNA damage, resulting in its localization to nuclear foci with other proteins (BRCA1 AND BRCA2) involved in homology-directed DNA repair. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
FANCD2 Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group D2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 3-10049351-T-C is Benign according to our data. Variant chr3-10049351-T-C is described in ClinVar as Benign. ClinVar VariationId is 257068.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.767 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FANCD2NM_001018115.3 linkc.1414-23T>C intron_variant Intron 16 of 43 ENST00000675286.1 NP_001018125.1 Q9BXW9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FANCD2ENST00000675286.1 linkc.1414-23T>C intron_variant Intron 16 of 43 NM_001018115.3 ENSP00000502379.1 Q9BXW9-2

Frequencies

GnomAD3 genomes
AF:
0.469
AC:
55328
AN:
118078
Hom.:
13119
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.774
Gnomad AMI
AF:
0.359
Gnomad AMR
AF:
0.328
Gnomad ASJ
AF:
0.386
Gnomad EAS
AF:
0.186
Gnomad SAS
AF:
0.260
Gnomad FIN
AF:
0.283
Gnomad MID
AF:
0.383
Gnomad NFE
AF:
0.347
Gnomad OTH
AF:
0.414
GnomAD2 exomes
AF:
0.206
AC:
39456
AN:
191370
AF XY:
0.191
show subpopulations
Gnomad AFR exome
AF:
0.759
Gnomad AMR exome
AF:
0.158
Gnomad ASJ exome
AF:
0.252
Gnomad EAS exome
AF:
0.0914
Gnomad FIN exome
AF:
0.121
Gnomad NFE exome
AF:
0.182
Gnomad OTH exome
AF:
0.200
GnomAD4 exome
AF:
0.279
AC:
278499
AN:
998934
Hom.:
35531
Cov.:
33
AF XY:
0.278
AC XY:
138905
AN XY:
499934
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.779
AC:
21386
AN:
27460
American (AMR)
AF:
0.232
AC:
7914
AN:
34166
Ashkenazi Jewish (ASJ)
AF:
0.355
AC:
6987
AN:
19682
East Asian (EAS)
AF:
0.132
AC:
3925
AN:
29676
South Asian (SAS)
AF:
0.222
AC:
14683
AN:
66174
European-Finnish (FIN)
AF:
0.250
AC:
9549
AN:
38134
Middle Eastern (MID)
AF:
0.314
AC:
1326
AN:
4224
European-Non Finnish (NFE)
AF:
0.271
AC:
199603
AN:
736590
Other (OTH)
AF:
0.306
AC:
13126
AN:
42828
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.340
Heterozygous variant carriers
0
11587
23174
34760
46347
57934
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6100
12200
18300
24400
30500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.469
AC:
55390
AN:
118176
Hom.:
13140
Cov.:
30
AF XY:
0.456
AC XY:
26216
AN XY:
57496
show subpopulations
African (AFR)
AF:
0.774
AC:
28570
AN:
36906
American (AMR)
AF:
0.327
AC:
3804
AN:
11628
Ashkenazi Jewish (ASJ)
AF:
0.386
AC:
1030
AN:
2666
East Asian (EAS)
AF:
0.186
AC:
683
AN:
3666
South Asian (SAS)
AF:
0.260
AC:
930
AN:
3572
European-Finnish (FIN)
AF:
0.283
AC:
2094
AN:
7390
Middle Eastern (MID)
AF:
0.373
AC:
82
AN:
220
European-Non Finnish (NFE)
AF:
0.347
AC:
17283
AN:
49820
Other (OTH)
AF:
0.412
AC:
662
AN:
1606
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.412
Heterozygous variant carriers
0
1057
2115
3172
4230
5287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
484
968
1452
1936
2420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.357
Hom.:
1361

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fanconi anemia complementation group D2 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary breast ovarian cancer syndrome Benign:1
Apr 19, 2022
National Health Laboratory Service, Universitas Academic Hospital and University of the Free State
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.41
DANN
Benign
0.67
PhyloP100
-0.48
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10222446; hg19: chr3-10091035; COSMIC: COSV55032714; COSMIC: COSV55032714; API